| 000 | 01544 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516152558.0 | ||
| 264 | 0 | _c20140108 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.00428-13 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPulido, David | |
| 245 | 0 | 0 |
_aTwo human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cAug 2013 |
||
| 300 |
_a3797-805 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aCell Membrane _xdrug effects |
| 650 | 0 | 4 | _aCell Membrane Permeability |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aEosinophil Cationic Protein _xchemical synthesis |
| 650 | 0 | 4 | _aGenes, Synthetic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aMicrobial Viability _xdrug effects |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aMycobacterium _xdrug effects |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 |
_aRibonucleases _xchemical synthesis |
| 700 | 1 | _aTorrent, Marc | |
| 700 | 1 | _aAndreu, David | |
| 700 | 1 | _aNogués, M Victoria | |
| 700 | 1 | _aBoix, Ester | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 57 _gno. 8 _gp. 3797-805 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.00428-13 _zAvailable from publisher's website |
| 999 |
_c22788500 _d22788500 |
||